Search research articles
Contact Us
Filters
Showing results (421-430 of 543) with videos related to
Page
of 55
Sort By:
Nuclear Medicine and Biology
|
June 27, 2007
Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3
Huma Mohsin, Jonathan Fitzsimmons, Tiffani Shelton, et al.
Nuclear Medicine and Biology
|
March 24, 2022
Development and biodistribution studies of <sup>77</sup>As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [<sup>77</sup>As]As-trithiol-Ser-Ser-RM2 vs. [<sup>77</sup>As]As-trithiol-Glu-Ser-RM2
Li Ma, Cameron Grant, Fabio Gallazzi, et al.
American Journal of Hematology
|
October 17, 2022
Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102
Rachel Cusatis, Michael J Martens, Ryotaro Nakamura, et al.
Leukemia & Lymphoma
|
October 19, 2017
Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells
Mark B Geyer, Shwetha H Manjunath, Andrew G Evans, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
July 17, 2016
Deuteron irradiation of W and WO3 for production of high specific activity (186)Re: Challenges associated with thick target preparation
Ethan R Balkin, Katherine Gagnon, Kevin T Strong, et al.
Bioconjugate Chemistry
|
November 8, 2011
Comparison of pretargeted and conventional CC49 radioimmunotherapy using 149Pm, 166Ho, and 177Lu
Huma Mohsin, Fang Jia, Jeffrey N Bryan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 19, 2013
Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease
Sarah Nikiforow, Haesook T Kim, Bhavjot Bindra, et al.
Bioconjugate Chemistry
|
March 16, 2006
Radiolanthanide-labeled monoclonal antibody CC49 for radioimmunotherapy of cancer: biological comparison of DOTA conjugates and 149Pm, 166Ho, and 177Lu
Huma Mohsin, Fang Jia, Geethapriya Sivaguru, et al.
Blood
|
January 27, 2009
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
Stefanie Sarantopoulos, Kristen E Stevenson, Haesook T Kim, et al.
Blood
|
November 16, 2017
Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease
Kathy S Wang, Haesook T Kim, Sarah Nikiforow, et al.
Page
of 55
Search research articles
Search
Showing results (421-430 of 543) with videos related to
Sort By:
Page
of 55
Nuclear Medicine and Biology
|
June 27, 2007
Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3
Huma Mohsin, Jonathan Fitzsimmons, Tiffani Shelton, et al.
Nuclear Medicine and Biology
|
March 24, 2022
Development and biodistribution studies of <sup>77</sup>As-labeled trithiol RM2 bioconjugates for prostate cancer: Comparison of [<sup>77</sup>As]As-trithiol-Ser-Ser-RM2 vs. [<sup>77</sup>As]As-trithiol-Glu-Ser-RM2
Li Ma, Cameron Grant, Fabio Gallazzi, et al.
American Journal of Hematology
|
October 17, 2022
Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102
Rachel Cusatis, Michael J Martens, Ryotaro Nakamura, et al.
Leukemia & Lymphoma
|
October 19, 2017
Concurrent therapy of chronic lymphocytic leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia utilizing CD19-targeted CAR T-cells
Mark B Geyer, Shwetha H Manjunath, Andrew G Evans, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|
July 17, 2016
Deuteron irradiation of W and WO3 for production of high specific activity (186)Re: Challenges associated with thick target preparation
Ethan R Balkin, Katherine Gagnon, Kevin T Strong, et al.
Bioconjugate Chemistry
|
November 8, 2011
Comparison of pretargeted and conventional CC49 radioimmunotherapy using 149Pm, 166Ho, and 177Lu
Huma Mohsin, Fang Jia, Jeffrey N Bryan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 19, 2013
Phase I study of alemtuzumab for therapy of steroid-refractory chronic graft-versus-host disease
Sarah Nikiforow, Haesook T Kim, Bhavjot Bindra, et al.
Bioconjugate Chemistry
|
March 16, 2006
Radiolanthanide-labeled monoclonal antibody CC49 for radioimmunotherapy of cancer: biological comparison of DOTA conjugates and 149Pm, 166Ho, and 177Lu
Huma Mohsin, Fang Jia, Geethapriya Sivaguru, et al.
Blood
|
January 27, 2009
Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
Stefanie Sarantopoulos, Kristen E Stevenson, Haesook T Kim, et al.
Blood
|
November 16, 2017
Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease
Kathy S Wang, Haesook T Kim, Sarah Nikiforow, et al.
Page
of 55